Popular searches: AAPL TSLA NVDA MSFT GOOGL

ASTH Stock Price Prediction 2027

Astrana Health Inc. Common Stock

$33.01
+$0.83 (+2.58%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: November 11, 2026

ASTH Price Forecast 2027: Our AI models project that ASTH stock will fall to approximately $30.28 by 2027. This represents a potential 8.3% contraction from the current trading price of $33.01. The overall market sentiment for ASTH is currently bearish, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading at a P/E ratio of 31.9, with its most recent quarterly earnings growing by 33.3%. ASTH shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 33.7, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • • TTM Squeeze just FIRED - potential breakout starting
  • • Moving averages converging - equilibrium state
  • • Volume showing distribution (CMF: -0.0712)
  • • Recent pattern: Belthold pattern detected
  • • Price near support at $32.18
MACD: Bearish | Volume: Distribution
Fair Value Estimate
+34.2% Undervalued
Fair Value: $44.29 (Current: $33.01)

Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 34.2% upside potential.

PEG Ratio
0.16
Attractive
Forward P/E
9.01
Fair P/E
12.09
Earnings Growth
57.9%
📉

Volume Trend: Distribution

Selling Pressure Present - Distribution pattern observed

Chaikin Money Flow (CMF): -0.071
Money Flow Index (MFI): 34.8

Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.

Options Analysis: 1-Year Target Strategy

Score: 0/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

STRONG SELL SIGNAL - Massively overpriced, excellent premium selling opportunity
Growth Target (1Y)
$23.06
+2.5% upside
Best Strike Found
$25.00
Exp: May 15, 2026, midnight
Call Premium
$2.60
11.6% of stock price
Breakeven Price
$27.60
⚠ Above target
Implied Probability
44.0%
Market's confidence
Value Score
-100.0
Overpriced
💰
STRONG SELL
Options are overpriced - Sell premium opportunity
Seller's Advantage:
Premium Collected
$2.60
Profit if Target Hits
$2.60
ROI if Target Hits
+100.0%
Why This Works: Buyers lose 100.0% even if target hits. Premium is overpriced for 2.5% move.
Suggested Strategies: Covered Call (safest) Naked Call (risky) Credit Spread (defined risk)
Open Interest: 5 | Volume: 1
Data as of: May 22, 2025
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
Timeframe Target Price Potential Return
30 Days $32.79 -0.7%
90 Days $32.33 -2.1%
6 Months $31.64 -4.1%
1 Year $30.28 -8.3%
2 Years EXTENDED $28.49 -13.7%
3 Years EXTENDED $26.81 -18.8%

More ASTH Analysis

Buy or Sell ASTH? ASTH Intrinsic Value & DCF ASTH Interactive Pro Chart Why is ASTH Moving? ASTH Trendline Analysis Stock Sector Rotation Tracker Supply Chain Money Flow Reddit & WSB Sentiment Backtested Stock Scanner
ASTH Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$37.85 (+14.7%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$30.28 (+-8.3%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$21.20 (-35.8%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
33.7
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
-0.07

Key Fundamentals

P/E Ratio
31.86
Forward P/E
9.01
P/S Ratio (TTM)
0.43x
Very Undervalued
Revenue Growth (QoQ)
0.1%
Earnings Growth (QoQ)
33.3%
Market Cap
$1,677M
Analyst Target
$52.11

Frequently Asked Questions

What is the ASTH stock price prediction for 2027?

Based on our AI analysis, ASTH is predicted to reach $30.28 by 2027, representing a potential 8.3% decrease from the current price of $33.01.

Is ASTH stock a good buy right now?

Our analysis suggests ASTH is a "AVOID" based on current technical and fundamental indicators. With a projected 8.3% downside, investors should consider their risk tolerance and investment horizon.

What is the technical analysis for ASTH?

ASTH is currently in a downtrend trend. The RSI of 33.7 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Where will ASTH stock be in 3 years?

Our long-term projection estimates ASTH could reach $26.81 by 2029, representing a 18.8% decline from current levels. Long-term predictions carry more uncertainty.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis